Faculty Opinions recommendation of A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT).
2020 ◽
Vol 26
(6)
◽
pp. 1195-1202
◽
2021 ◽
Vol 27
(3)
◽
pp. S151-S152
2018 ◽
Vol 59
(11)
◽
pp. 2727-2730
◽
2020 ◽
Vol 55
(7)
◽
pp. 1264-1271
◽
2020 ◽
Vol 26
(9)
◽
pp. 1597-1606